RegBase
日本語
Japanese original

グラクソ・スミスクライン株式会社

グラクソ・スミスクライン株式会社· Corporate Number: 2011001026329

For developers: integration details

You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.

/api/v1/search?q=2011001026329&limit=5
Open API responseAPI docs

Public Record Summary

Actions in last 3 years
0records
Actions in last year
0records
Latest action
about 4 years ago

27 Sept 2021

Total penalties
-

Enforcement and administrative action history

医薬品医療機器等法特例承認
Confirmed entity match

Name of the COVID-19 treatment drug: Zevudy intravenous infusion 500mg, Generic name: Sotrovimab (recombinant), Applicant: GlaxoSmithKline K.K., Application date: September 6, 2021.

27 Sept 2021Ministry of Health, Labour and Welfare
Open source archiveCheck original source

Language

日本語版を見る (Japanese)

Registry data

English name
グラクソ・スミスクライン株式会社
Japanese name
グラクソ・スミスクライン株式会社
Corporate Number
2011001026329
Registered address
東京都港区赤坂１丁目８番１号
Status
Active

Note: This company may not have detailed gBizINFO data, or RegBase has not completed enrichment yet. The public sources below may contain supplemental registry information.

View on gBizINFO ↗View on National Tax Agency Corporate Number site ↗

gBizINFO: fetched 25 Apr 2026

Data sources

Breakdown by law

  • 医薬品医療機器等法
    1

Breakdown by action type

  • 特例承認
    1

About this English name

No official English name source is recorded. The original Japanese name is shown.

If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.

This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.